首页> 外文期刊>Tumour biology : >Overexpression of SphK1 enhances cell proliferation and invasion in triple-negative breast cancer via the PI3K/AKT signaling pathway
【24h】

Overexpression of SphK1 enhances cell proliferation and invasion in triple-negative breast cancer via the PI3K/AKT signaling pathway

机译:SphK1的过表达通过PI3K / AKT信号通路增强三阴性乳腺癌中的细胞增殖和侵袭

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Sphingosine kinase 1 (SphK1) expression is elevated in various cancers and is associated with shorter survival times for patients. However, the molecular mechanism of SphK1 up-regulation in triple-negative breast cancer (TNBC) remains unclear. In this study, we assayed the expression level of SphK1 in TNBC tissues by qRT-PCR and immunohistochemistry. The level of S1P was quantified by ELISA in the serum of TNBC patients. Our results found that the levels of SphK1 and S1P were significantly increased in TNBC patients compared with normal control. Furthermore, knockdown of SphK1 with siRNA decreased TNBC cell proliferation and inhibited cell migration/invasion. These data suggest that SphK1 has an important role in TNBC and presents an attractive therapeutic target for the treatment for TNBC.
机译:鞘氨醇激酶1(SphK1)的表达在各种癌症中升高,并与患者较短的生存时间有关。但是,SphK1上调在三阴性乳腺癌(TNBC)中的分子机制仍不清楚。在这项研究中,我们通过qRT-PCR和免疫组化分析了SphK1在TNBC组织中的表达水平。通过ELISA定量TNBC患者血清中的S1P水平。我们的结果发现,与正常对照组相比,TNBC患者的SphK1和S1P水平显着增加。此外,用siRNA敲低SphK1可降低TNBC细胞增殖并抑制细胞迁移/侵袭。这些数据表明,SphK1在TNBC中具有重要作用,并为TNBC的治疗提出了有吸引力的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号